Effect of intravenous dopamine infusion on plasma concentrations of dopamine and dopamine sulfate in men, during and up to 18 h after infusion

European Journal of Clinical Pharmacology

Volumn 55, Issue 10, 2000, Pages 755-759

  Onasch, A ^a   Boning D ^a   Strobel, G ^a   Tanzeem, A ^b   Isgro, F ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Institute of Heart Surgery   (Germany)

Author keywords

Dopamine; Pharmacokinetics; Sulfoconjugation

Indexed keywords

DOPAMINE; DOPAMINE DERIVATIVE; DOPAMINE SULFATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; DRUG HALF LIFE; HEART RATE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

EID: 0033959618     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050010     Document Type: Article

References (38)

1. 1. Weicker H (1988) Determination of free and sulfoconjugated catecholamines in plasma and urine by high performance liquid chromatography. Int J Sports Med 9: 89-92
2. 2. Johnson GA, Baker CA, Smith RT (1980) Radioenzymatic assay of sulfate conjugates of catecholamines and dopa in plasma. Life Sci 26: 1591-1598
3. 3. Kopin JL (1985) Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 37: 333-367
4. 4. Kuchel O, Buu NT, Racz K, De Lean A, Serri O, Kyncl J (1986) Role of sulfate conjugation of catecholamines in blood pressure regulation. Federation Proc 45: 2254-2259
5. 5. Werle E, Lenz T, Strobel G, Weicker H (1988) 3-and 4-0-sulfoconjugated and methylated dopamine: Highly reduced binding affinity to dopamine D2 receptors in striatal membranes. Naunyn Schmiedebergs Arch Pharmacol 338: 28-34
6. 6. Werle E, Michel G, Lenz T, Kather H, Schneider B, Weicker H (1988) Restricted alpha-and beta-adrenoceptor affinity of sulfoconjugated catecholamines in human mononuclear leucocytes, platelets, and fat cells and reduction of the postreceptor mechanism. Int J Sports Med 9: 93-102
7. 7. Ratge D, Steegmüller U, Mikus G, Kohse KP, Wisser H (1990) Dopamine infusion healthy in healthy subjects and critically ill patients. Clin Exp Pharmacol Physiol 17: 361-369
8. 8. Davidson L, Vandongen R, Beilin LJ (1981) Effect of eating bananas on plasma free and sulfate-conjugated catecholamines. Life Sci 29: 1773-1778
9. 9. Hashizume K, Yamatodani A, Yamamoto T, Ogihara T, Kumahara Y, Wada H (1987) Effects of oral and intravenous administration of dopamine and L-dopa on plasma levels of two isomers of dopamine sulfate in man. Life Sci 41: 2697-2704
10. 10. Anton AH (1987) Dopamine sulphoconjugate: A catecholamine Gordian knot. J Lab Clin Med 87: 523-525
11. 11. Weiner N (1985) Norepinephrine, epinephrine and the sympathomimetic amines. In: Gilman A, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. Macmillan Publishing, New York, pp 145-180
12. 12. Renskers KJ, Feor KD, Roth JA (1980) Sulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase. J Neurochem 34: 1362-1368
13. 13. Ratge D, Knoll E, Wiser H (1986) Plasma free and conjugated catecholamines in clinical disorders. Life Sci 39: 557-564
14. 14. Tyce GM, Van Dyke RA, Rettke SR (1987) Human liver and conjugation of catecholamines. J Lab Clin Med 109: 532-537
15. 15. Jones AL, Roberts RC, Coughtrie MWH (1993) The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein. Biochem J 296: 287-290
16. 16. Merits I (1976) Formation and metabolism of C dopamine3-O-sulfate in dog, rat and guinea pig. Biochem Pharmacol 25: 829-833
17. 17. Demassieux S, Romain Y, Bordelaux L, Gravel D, Carrier S (1986) The activity of human kidney arylsulfatase A and B towards catecholamine sulfates. Biochem Cell Biol 64: 1044-1048
18. 18. Strobel G, Werle E, Weicker H (1990) Isomer specific kinetics of dopamine beta-hydroxylase and arylsulfatase towards catecholamine sulfates. Biochem Int 20: 343-351
19. 19. Nakaya Y, Katayama T, Nomura M, Ishimura Y, Ohuchi T, Oka M, Yamamoto M, Mizobuchi S (1994) Pathophysiologic significance of free and conjugated dopamines in congestive heart failure. Am Heart J 127: 613-617
20. 20. Strobel G, Weicker H (1991) Catecholamine sulfates as internal standards in HPLC determinations of sulfoconjugated catecholamines in plasma and urine. Clin Chem 37: 196-199
21. 21. Strobel G, Werle E, Hellinger H, Griebel D, Weicker H (1988) Syntheses of the sulfoconjugated isomers of norepinephrine and dopamine, controlled by HPLC with ultraviolet detection. Eur J Biochem 176: 397-402
22. 22. Peck CC, Barrett BB (1979) Nonlinear least-squares regression programs for microcomputers. J Pharmacokinet Biopharm 7: 537-541
23. 23. Kahane Z, Esser AH, Kline NS, Vestergaaed P (1967) Estimation of conjugated epinephrine and norepinephrine in urine. J Lab Clin Med 69: 1042-1050
24. 24. Claustre J, Pequignot JM, Bui-xuan B, Muchada R, Cottet-Emard RM, Peyrin L (1990) Conjugation and deamination of circulating dopamine: Relationship between sulfated and free dopamine in man. J Auton Nerv Syst 29: 175-182
25. 25. Kho TL, Punt R (1982) Systemic haemodynamic effects of dopamine in hypertensive patients rendered normotensive after acute myocardial infarction. Neth J Med 25: 332-337
26. 26. Kho TL, Punt R (1982) Cardiovascular effects of dobutamine in hypertensive patients whose blood pressure returned to normal after acute myocardial infarction. Neth J Med 25: 338-343
27. 27. Le Corre P, Malledant Y, Tanguy M, Le Verge R (1993) Steady-state pharmacokinetics of dopamine in adult patients. Crit Care Med 21: 1652-1657
28. 28. Weinshilboum RM, Aksoy I (1994) Sulfation pharmacogenetics in man. Chem Biol Interact 92: 233-246
29. 29. Levy G (1986) Sulfate conjugation in drug metabolism: Role of inorganic sulfate. Fed Proc 45: 2235-2240
30. 30. Ratge D, Kohse KP, Steegmüller U, Wisser H (1991) Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: Different effects of intravenous and oral catecholamine administration. J Pharmacol Exp Ther 257: 232-238
31. 31. Kuchel O, Buu NT, Fontaine A, Hamet P, Beroniade V, Larochelle P, Genest J (1980) Free and conjugated plasma catecholamines in hypertensive patients with and without pheochromocytoma. Hypertension 2: 177-186
32. 32. Kuchel O, Buu NT, Hamet P, Larochelle P, Bourque M, Genest J (1981) Essential hypertension with low conjugated catecholamines imitates pheochromocytoma. J Clin Endocrinol Metab 54: 1268-1270
33. 33. Houston JB, Wilkens HJ, Levy G (1986) Potentiation of isoproterenol effect by ascorbic acid. Res Commun Chem Pathol Pharmacol 14: 243-250
34. 34. Vandongen R (1984) The significance of sulfate-conjugated catecholamines in man. Neth J Med 27: 129-135
35. 35. Dunne JW, Davidson L, Vandongen R, Beilin LJ, Rogers P (1983) The effect of ascorbic acid on plasma sulfate conjugated catecholamines after eating bananas. Life Sci 33: 151-157
36. 36. Gundert-Remy U, Penzien J, Hildebrandt R (1984) Correlation between the pharmakokinetics and pharmacodynamics of dopamine in healthy subjects. Eur J Clin Pharmacol 26: 163-169
37. 37. Cuche JL, Brochier P, Klioua N, Poirier MF, Cuche H, Bennmiloud M, Loo H, Safar M (1990) Conjugated catecholamines in human plasma: Where are they coming from? J Lab Clin Med 116: 681-686
38. 38. Chamberlain KG, Pestell RG, Best JD (1990) Platelet catecholamine contents are cumulative indexes of sympathoadrenal activity. Am J Physiol 259: 141-147